Pinsent Masons tops the AIM Advisers Rankings Guide

08 Aug 2013 | 05:07 pm |

International law firm Pinsent Masons has retained first place in the latest AIM Advisers Rankings guide, with a total of 56 clients quoted on the junior market.

The firm won a total of seven new clients in the industrial, consumer goods and services, technology and oil and gas sectors with three new clients won in the latter.

New additions include biopharmaceuticals company Valirx Plc and Latin American power company Rurelec Plc.

Pinsent Masons’ corporate partner and capital markets specialist, Sean Page, said:

"Our AIM expertise has enabled us to dominate the rankings for some time. It's good to see that we continue to secure new clients both domestic and international despite challenging market conditions.

"Our capital markets practice is based around our sector-led proposition and breadth of coverage – maintaining our number one AIM ranking also being ranked second for all quoted clients is a testament to this approach."

Earlier this year, the firm capitalised on its experience in both the main and junior markets advising AIM-quoted manufacturer Tyman Plc on its $200 million acquisition of Truth Hardware moving up to the London Stock Exchange (LSE) main market.

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

Pinsent Masons advises ALK Capital on its acquisition of Burnley FC

Multinational law firm Pinsent Masons has advised ALK Capital on the acquisition of Burnley Football Club.

Pinsent Masons advises Unbound on financing in fitness start-up VAHA

Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts